APO Research
Talk to an analyst

APO RESEARCH · REPORT

lrinotecan

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global lrinotecan Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry Researchlrinotecan Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal lrinotecan Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal lrinotecan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal lrinotecan Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal lrinotecan Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global lrinotecan market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for lrinotecan is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for lrinotecan is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for lrinotecan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of lrinotecan include Actiza Pharmaceutical, Cipla, Getwell, Salius, Taj Pharma, West-ward Pharmaceuticals, Pfizer and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global lrinotecan market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The lrinotecan market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global lrinotecan market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to lrinotecan.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global lrinotecan market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

lrinotecan Market by Company

Actiza Pharmaceutical

Cipla

Getwell

Salius

Taj Pharma

West-ward Pharmaceuticals

Pfizer

Teva

lrinotecan Segment by Type

Irinotecan Hydrochloride Injection 40mg

Irinotecan Hydrochloride Injection 100mg

Others

lrinotecan Segment by Application

Clinic

Hospital

Others

lrinotecan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global lrinotecan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of lrinotecan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of lrinotecan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of lrinotecan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of lrinotecan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Irinotecan Hydrochloride Injection 40mg Table 2. Major Company of Irinotecan Hydrochloride Injection 100mg Table 3. Major Company of Others Table 4. Global lrinotecan Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global lrinotecan Sales by Type (2021-2026) & (k units) Table 6. Global lrinotecan Sales Market Share in Volume by Type (2021-2026) Table 7. Global lrinotecan Sales by Type (2021-2026) & (US$ Million) Table 8. Global lrinotecan Sales Market Share in Value by Type (2021-2026) Table 9. Global lrinotecan Price by Type (2021-2026) & (US$/unit) Table 10. Global lrinotecan Sales by Type (2027-2032) & (k units) Table 11. Global lrinotecan Sales Market Share in Volume by Type (2027-2032) Table 12. Global lrinotecan Sales by Type (2027-2032) & (US$ Million) Table 13. Global lrinotecan Sales Market Share in Value by Type (2027-2032) Table 14. Global lrinotecan Price by Type (2027-2032) & (US$/unit) Table 15. North America lrinotecan Sales by Type (2021-2026) & (k units) Table 16. North America lrinotecan Sales by Type (2021-2026) & (US$ Million) Table 17. Europe lrinotecan Sales by Type (2021-2026) & (k units) Table 18. Europe lrinotecan Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific lrinotecan Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific lrinotecan Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America lrinotecan Sales by Type (2021-2026) & (k units) Table 22. Latin America lrinotecan Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa lrinotecan Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa lrinotecan Sales by Type (2021-2026) & (US$ Million) Table 25. lrinotecan Industry Trends Table 26. lrinotecan Industry Drivers Table 27. lrinotecan Industry Opportunities and Challenges Table 28. lrinotecan Industry Restraints Table 29. Global lrinotecan Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global lrinotecan Revenue Market Share by Company (2021-2026) Table 31. Global lrinotecan Sales by Company (2021-2026) & (k units) Table 32. Global lrinotecan Sales Share by Company (2021-2026) Table 33. Global lrinotecan Market Price by Company (2021-2026) & (US$/unit) Table 34. Global lrinotecan Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global lrinotecan Major Company Production Sites and Headquarters Table 36. Global lrinotecan Company, Product Type & Application Table 37. Global lrinotecan Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global lrinotecan by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global lrinotecan Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global lrinotecan Sales by Region (2021-2026) & (k units) Table 42. Global lrinotecan Sales Market Share in Volume by Region (2021-2026) Table 43. Global lrinotecan Sales by Region (2021-2026) & (US$ Million) Table 44. Global lrinotecan Sales Market Share in Value by Region (2021-2026) Table 45. Global lrinotecan Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global lrinotecan Sales by Region (2027-2032) & (k units) Table 47. Global lrinotecan Sales Market Share in Volume by Region (2027-2032) Table 48. Global lrinotecan Sales by Region (2027-2032) & (US$ Million) Table 49. Global lrinotecan Sales Market Share in Value by Region (2027-2032) Table 50. Global lrinotecan Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global lrinotecan Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global lrinotecan Sales by Application (2021-2026) & (k units) Table 53. Global lrinotecan Sales Market Share in Volume by Application (2021-2026) Table 54. Global lrinotecan Sales by Application (2021-2026) & (US$ Million) Table 55. Global lrinotecan Sales Market Share in Value by Application (2021-2026) Table 56. Global lrinotecan Price by Application (2021-2026) & (US$/unit) Table 57. Global lrinotecan Sales by Application (2027-2032) & (k units) Table 58. Global lrinotecan Sales Market Share in Volume by Application (2027-2032) Table 59. Global lrinotecan Sales by Application (2027-2032) & (US$ Million) Table 60. Global lrinotecan Sales Market Share in Value by Application (2027-2032) Table 61. Global lrinotecan Price by Application (2027-2032) & (US$/unit) Table 62. North America lrinotecan Sales by Application (2021-2026) & (k units) Table 63. North America lrinotecan Sales by Application (2021-2026) & (US$ Million) Table 64. Europe lrinotecan Sales by Application (2021-2026) & (k units) Table 65. Europe lrinotecan Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific lrinotecan Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific lrinotecan Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America lrinotecan Sales by Application (2021-2026) & (k units) Table 69. Latin America lrinotecan Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa lrinotecan Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa lrinotecan Sales by Application (2021-2026) & (US$ Million) Table 72. Actiza Pharmaceutical Company Information Table 73. Actiza Pharmaceutical Business Overview Table 74. Actiza Pharmaceutical lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Actiza Pharmaceutical lrinotecan Product Portfolio Table 76. Actiza Pharmaceutical Recent Development Table 77. Cipla Company Information Table 78. Cipla Business Overview Table 79. Cipla lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Cipla lrinotecan Product Portfolio Table 81. Cipla Recent Development Table 82. Getwell Company Information Table 83. Getwell Business Overview Table 84. Getwell lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Getwell lrinotecan Product Portfolio Table 86. Getwell Recent Development Table 87. Salius Company Information Table 88. Salius Business Overview Table 89. Salius lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Salius lrinotecan Product Portfolio Table 91. Salius Recent Development Table 92. Taj Pharma Company Information Table 93. Taj Pharma Business Overview Table 94. Taj Pharma lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Taj Pharma lrinotecan Product Portfolio Table 96. Taj Pharma Recent Development Table 97. West-ward Pharmaceuticals Company Information Table 98. West-ward Pharmaceuticals Business Overview Table 99. West-ward Pharmaceuticals lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. West-ward Pharmaceuticals lrinotecan Product Portfolio Table 101. West-ward Pharmaceuticals Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Pfizer lrinotecan Product Portfolio Table 106. Pfizer Recent Development Table 107. Teva Company Information Table 108. Teva Business Overview Table 109. Teva lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Teva lrinotecan Product Portfolio Table 111. Teva Recent Development Table 112. North America lrinotecan Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. North America lrinotecan Sales by Country (2021-2026) & (k units) Table 114. North America lrinotecan Sales Market Share by Country (2021-2026) Table 115. North America lrinotecan Sales Forecast by Country (2027-2032) & (k units) Table 116. North America lrinotecan Sales Market Share Forecast by Country (2027-2032) Table 117. North America lrinotecan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America lrinotecan Market Size by Country (2021-2026) & (US$ Million) Table 119. North America lrinotecan Market Share by Country (2021-2026) Table 120. North America lrinotecan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America lrinotecan Market Share Forecast by Country (2027-2032) Table 122. Europe lrinotecan Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Europe lrinotecan Sales by Country (2021-2026) & (k units) Table 124. Europe lrinotecan Sales Market Share by Country (2021-2026) Table 125. Europe lrinotecan Sales Forecast by Country (2027-2032) & (k units) Table 126. Europe lrinotecan Sales Market Share Forecast by Country (2027-2032) Table 127. Europe lrinotecan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe lrinotecan Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe lrinotecan Market Share by Country (2021-2026) Table 130. Europe lrinotecan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe lrinotecan Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific lrinotecan Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific lrinotecan Sales by Country (2021-2026) & (k units) Table 134. Asia-Pacific lrinotecan Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific lrinotecan Sales Forecast by Country (2027-2032) & (k units) Table 136. Asia-Pacific lrinotecan Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific lrinotecan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific lrinotecan Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific lrinotecan Market Share by Country (2021-2026) Table 140. Asia-Pacific lrinotecan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific lrinotecan Market Share Forecast by Country (2027-2032) Table 142. Latin America lrinotecan Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Latin America lrinotecan Sales by Country (2021-2026) & (k units) Table 144. Latin America lrinotecan Sales Market Share by Country (2021-2026) Table 145. Latin America lrinotecan Sales Forecast by Country (2027-2032) & (k units) Table 146. Latin America lrinotecan Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America lrinotecan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America lrinotecan Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America lrinotecan Market Share by Country (2021-2026) Table 150. Latin America lrinotecan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America lrinotecan Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa lrinotecan Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa lrinotecan Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa lrinotecan Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa lrinotecan Sales Forecast by Country (2027-2032) & (k units) Table 156. Middle East and Africa lrinotecan Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa lrinotecan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa lrinotecan Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa lrinotecan Market Share by Country (2021-2026) Table 160. Middle East and Africa lrinotecan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa lrinotecan Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. lrinotecan Distributors List Table 165. lrinotecan Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. lrinotecan Image Figure 2. Global lrinotecan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global lrinotecan Market Size (2021-2032) & (US$ Million) Figure 4. Global lrinotecan Sales (2021-2032) & (k units) Figure 5. Irinotecan Hydrochloride Injection 40mg Image Figure 6. Global Irinotecan Hydrochloride Injection 40mg Sales YoY Growth (2021-2032) & (k units) Figure 7. Irinotecan Hydrochloride Injection 100mg Image Figure 8. Global Irinotecan Hydrochloride Injection 100mg Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global lrinotecan Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global lrinotecan Market Share by Type 2025 VS 2032 Figure 13. North America lrinotecan Sales Market Share in Volume by Type in 2025 Figure 14. North America lrinotecan Sales Market Share in Value by Type in 2025 Figure 15. Europe lrinotecan Sales Market Share in Volume by Type in 2025 Figure 16. Europe lrinotecan Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific lrinotecan Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific lrinotecan Sales Market Share in Value by Type in 2025 Figure 19. Latin America lrinotecan Sales Market Share in Volume by Type in 2025 Figure 20. Latin America lrinotecan Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa lrinotecan Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa lrinotecan Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 lrinotecan Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global lrinotecan Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global lrinotecan Market Share by Application 2025 VS 2032 Figure 33. North America lrinotecan Sales Market Share in Volume by Application in 2025 Figure 34. North America lrinotecan Sales Market Share in Value by Application in 2025 Figure 35. Europe lrinotecan Sales Market Share in Volume by Application in 2025 Figure 36. Europe lrinotecan Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific lrinotecan Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific lrinotecan Sales Market Share in Value by Application in 2025 Figure 39. Latin America lrinotecan Sales Market Share in Volume by Application in 2025 Figure 40. Latin America lrinotecan Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa lrinotecan Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa lrinotecan Sales Market Share in Value by Application in 2025 Figure 43. North America lrinotecan Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America lrinotecan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America lrinotecan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America lrinotecan Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe lrinotecan Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe lrinotecan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe lrinotecan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe lrinotecan Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific lrinotecan Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific lrinotecan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific lrinotecan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific lrinotecan Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America lrinotecan Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America lrinotecan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America lrinotecan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America lrinotecan Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa lrinotecan Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa lrinotecan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa lrinotecan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa lrinotecan Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. lrinotecan Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. lrinotecan Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Irinotecan Hydrochloride Injection 40mg
  • Irinotecan Hydrochloride Injection 100mg
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Actiza Pharmaceutical
  • Cipla
  • Getwell
  • Salius
  • Taj Pharma
  • West-ward Pharmaceuticals
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global lrinotecan Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global lrinotecan Sales Estimates and Forecasts (2021-2032)
  5. 1.3 lrinotecan Market by Type
  6. 1.3.1 Irinotecan Hydrochloride Injection 40mg
  7. 1.3.2 Irinotecan Hydrochloride Injection 100mg
  8. 1.3.3 Others
  9. 1.4 Global lrinotecan Market Size by Type
  10. 1.4.1 Global lrinotecan Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global lrinotecan Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global lrinotecan Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America lrinotecan Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe lrinotecan Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific lrinotecan Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America lrinotecan Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa lrinotecan Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 lrinotecan Industry Trends
  2. 2.2 lrinotecan Industry Drivers
  3. 2.3 lrinotecan Industry Opportunities and Challenges
  4. 2.4 lrinotecan Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by lrinotecan Revenue (2021-2026)
  2. 3.2 Global Top Players by lrinotecan Sales (2021-2026)
  3. 3.3 Global Top Players by lrinotecan Price (2021-2026)
  4. 3.4 Global lrinotecan Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global lrinotecan Major Company Production Sites & Headquarters
  6. 3.6 Global lrinotecan Company, Product Type & Application
  7. 3.7 Global lrinotecan Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global lrinotecan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 lrinotecan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 lrinotecan Tier 1, Tier 2, and Tier 3
4 lrinotecan Regional Status and Outlook
  1. 4.1 Global lrinotecan Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global lrinotecan Historic Market Size by Region
  3. 4.2.1 Global lrinotecan Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global lrinotecan Sales in Value by Region (2021-2026)
  5. 4.2.3 Global lrinotecan Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global lrinotecan Forecasted Market Size by Region
  7. 4.3.1 Global lrinotecan Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global lrinotecan Sales in Value by Region (2027-2032)
  9. 4.3.3 Global lrinotecan Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 lrinotecan by Application
  1. 5.1 lrinotecan Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global lrinotecan Market Size by Application
  6. 5.2.1 Global lrinotecan Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global lrinotecan Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global lrinotecan Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America lrinotecan Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe lrinotecan Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific lrinotecan Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America lrinotecan Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa lrinotecan Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actiza Pharmaceutical
  2. 6.1.1 Actiza Pharmaceutical Company Information
  3. 6.1.2 Actiza Pharmaceutical Business Overview
  4. 6.1.3 Actiza Pharmaceutical lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actiza Pharmaceutical lrinotecan Product Portfolio
  6. 6.1.5 Actiza Pharmaceutical Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla lrinotecan Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Getwell
  14. 6.3.1 Getwell Company Information
  15. 6.3.2 Getwell Business Overview
  16. 6.3.3 Getwell lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Getwell lrinotecan Product Portfolio
  18. 6.3.5 Getwell Recent Developments
  19. 6.4 Salius
  20. 6.4.1 Salius Company Information
  21. 6.4.2 Salius Business Overview
  22. 6.4.3 Salius lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Salius lrinotecan Product Portfolio
  24. 6.4.5 Salius Recent Developments
  25. 6.5 Taj Pharma
  26. 6.5.1 Taj Pharma Company Information
  27. 6.5.2 Taj Pharma Business Overview
  28. 6.5.3 Taj Pharma lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taj Pharma lrinotecan Product Portfolio
  30. 6.5.5 Taj Pharma Recent Developments
  31. 6.6 West-ward Pharmaceuticals
  32. 6.6.1 West-ward Pharmaceuticals Company Information
  33. 6.6.2 West-ward Pharmaceuticals Business Overview
  34. 6.6.3 West-ward Pharmaceuticals lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 West-ward Pharmaceuticals lrinotecan Product Portfolio
  36. 6.6.5 West-ward Pharmaceuticals Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer lrinotecan Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Teva
  44. 6.8.1 Teva Company Information
  45. 6.8.2 Teva Business Overview
  46. 6.8.3 Teva lrinotecan Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva lrinotecan Product Portfolio
  48. 6.8.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America lrinotecan Sales by Country
  2. 7.1.1 North America lrinotecan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America lrinotecan Sales by Country (2021-2026)
  4. 7.1.3 North America lrinotecan Sales Forecast by Country (2027-2032)
  5. 7.2 North America lrinotecan Market Size by Country
  6. 7.2.1 North America lrinotecan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America lrinotecan Market Size by Country (2021-2026)
  8. 7.2.3 North America lrinotecan Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe lrinotecan Sales by Country
  2. 8.1.1 Europe lrinotecan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe lrinotecan Sales by Country (2021-2026)
  4. 8.1.3 Europe lrinotecan Sales Forecast by Country (2027-2032)
  5. 8.2 Europe lrinotecan Market Size by Country
  6. 8.2.1 Europe lrinotecan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe lrinotecan Market Size by Country (2021-2026)
  8. 8.2.3 Europe lrinotecan Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific lrinotecan Sales by Country
  2. 9.1.1 Asia-Pacific lrinotecan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific lrinotecan Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific lrinotecan Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific lrinotecan Market Size by Country
  6. 9.2.1 Asia-Pacific lrinotecan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific lrinotecan Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific lrinotecan Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America lrinotecan Sales by Country
  2. 10.1.1 South America lrinotecan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America lrinotecan Sales by Country (2021-2026)
  4. 10.1.3 South America lrinotecan Sales Forecast by Country (2027-2032)
  5. 10.2 South America lrinotecan Market Size by Country
  6. 10.2.1 South America lrinotecan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America lrinotecan Market Size by Country (2021-2026)
  8. 10.2.3 South America lrinotecan Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa lrinotecan Sales by Country
  2. 11.1.1 Middle East and Africa lrinotecan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa lrinotecan Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa lrinotecan Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa lrinotecan Market Size by Country
  6. 11.2.1 Middle East and Africa lrinotecan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa lrinotecan Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa lrinotecan Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 lrinotecan Value Chain Analysis
  2. 12.1.1 lrinotecan Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 lrinotecan Production Mode & Process
  7. 12.2 lrinotecan Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 lrinotecan Distributors
  10. 12.2.3 lrinotecan Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst